Xiaoling Su Selected Research

Xiaoling Su Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 01/2015
6	Infections 03/2024 - 01/2021
2	COVID-19 03/2024 - 12/2022
2	Reperfusion Injury 07/2023 - 06/2023
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2023 - 06/2023
2	Hypertension (High Blood Pressure) 11/2022 - 10/2022
2	Heart Failure 10/2022 - 01/2022
2	Cardiac Arrhythmias (Arrythmia) 10/2022 - 01/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2018
1	Breakthrough Infections 12/2023
1	Reinfection 12/2023
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Left Ventricular Dysfunction 01/2022
1	Pulmonary Arterial Hypertension 01/2022
1	Chronic Hepatitis B 11/2021
1	Virus Diseases (Viral Diseases) 10/2021
1	Coronary Disease (Coronary Heart Disease) 03/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Cardiomegaly (Heart Hypertrophy) 09/2020
1	Hypertrophy 09/2020
1	Fistula 12/2019
1	Pathologic Constriction (Stenosis) 12/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019
1	Weight Loss (Weight Reduction) 09/2017
1	Carcinoma (Carcinomatosis) 09/2017
1	Spontaneous Abortion (Miscarriage) 06/2017
1	Osteoarthritis 01/2017
1	Disease Progression 01/2017
1	Fibrosis (Cirrhosis) 01/2016

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
3	Neutralizing AntibodiesIBA 03/2024 - 12/2022
3	Lysine (L-Lysine)FDA Link 07/2023 - 07/2022
3	MicroRNAs (MicroRNA)IBA 06/2023 - 01/2018
2	VaccinesIBA 03/2024 - 01/2021
2	Messenger RNA (mRNA)IBA 03/2024 - 06/2017
2	Inactivated VaccinesIBA 03/2024 - 12/2023
2	CalciumIBA 10/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2016
2	Competitive Endogenous RNAIBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2017
1	mRNA VaccinesIBA 03/2024
1	AntigensIBA 12/2023
1	Annexin A2 (Annexin II)IBA 12/2023
1	LigandsIBA 12/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	CrizotinibIBA 01/2023
1	alectinibIBA 01/2023
1	C-Type Lectins (C-Type Lectin)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 12/2022
1	EpitopesIBA 12/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 11/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	dapagliflozinIBA 01/2022
1	SodiumIBA 01/2022
1	Hepatitis B e AntigensIBA 11/2021
1	feralIBA 10/2021
1	Peptides (Polypeptides)IBA 10/2021
1	Histocompatibility Antigens Class IIBA 10/2021
1	CholesterolIBA 03/2021
1	ExotoxinsIBA 01/2021
1	Contrast MediaIBA 01/2021
1	myosin light chain 2IBA 09/2020
1	calpain inhibitorsIBA 09/2020
1	Myosin-Light-Chain KinaseIBA 09/2020
1	calpeptinIBA 09/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2020
1	CalpainIBA 09/2020
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2020
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2018
1	PlatinumIBA 09/2017
1	cuprous oxideIBA 09/2017
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2017
1	IsotopesIBA 01/2017
1	Fenofibrate (CiL)FDA LinkGeneric 01/2017

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2023 - 09/2017
1	Aftercare (After-Treatment) 12/2019